Infographic on oncology in Latin America

Examining the Uptake of Biomarker-Driven Prescribing

Up to 50% of eligible public patient's aren't treated with biomarket-driven agents.

Approximately 1 month to receive test results - a further barrier to the uptake of biomarker-driven agents.

Download the Oncology in Latin America infographic to learn more.

 

Download

 

 

Download

 

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now